Have a personal or library account? Click to login
Adhesion Molecules and Vulnerable Plaques – Promoters of Acute Coronary Syndromes Cover

Adhesion Molecules and Vulnerable Plaques – Promoters of Acute Coronary Syndromes

Open Access
|Jan 2023

References

  1. 1. Choy SY, Mintz GS. What have we learned about plaque rupture in acute coronary syndromes? Curr Cardiol Rep. 2010;12:338-343. doi: 10.1007/s11886-010-0113-x.20425160
  2. 2. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733-743. doi: 10.1161/01.cir.79.4.733.2647318
  3. 3. Stefanadis C, Antoniou CK, Tsiachris D, Petri P. Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives. J Am Heart Assoc. 2017;6:e005543. doi: 10.1161/JAHA.117.005543.552404428314799
  4. 4. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275. doi: 10.1161/01.atv.20.5.1262.10807742
  5. 5. Huang X, Yang C, Zheng J, et al. 3D MRI-based multicomponent thin layer structure only plaque models for atherosclerotic plaques. J Biomech. 2016;49:2726-2733. doi: 10.1016/j.jbiomech.2016.06.002.506639427344199
  6. 6. Brown AJ, Teng Z, Evans PC, Gillard JH, Samady H, Bennett MR. Role of biomechanical forces in the natural history of coronary atherosclerosis. Nat Rev Cardiol. 2016;13:210-220. doi: 10.1038/nrcardio.2015.203.26822720
  7. 7. Ohayon J, Teppaz P, Finet G, Rioufol G. In-vivo prediction of human coronary plaque rupture location using intravascular ultrasound and the finite element method. Coron Artery Dis. 2001;12:655-663. doi: 10.1097/00019501-200112000-00009.11811331
  8. 8. Teng Z, Brown AJ, Calvert PA, et al. Coronary plaque structural stress is associated with plaque composition and subtype and higher in acute coronary syndrome: the BEACON I (biomechanical evaluation of atheromatous coronary arteries) study. Circ Cardiovasc Imaging. 2014;7:461-470. doi: 10.1161/CIRCIMAGING.113.001526.24557858
  9. 9. Arbab-Zadeh A, Fuster V. From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient: JACC State-ofthe-Art Review. J Am Coll Cardiol. 2019;74:1582-1593. doi: 10.1016/j.jacc.2019.07.062.31537269
  10. 10. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278:483-493. doi: 10.1111/joim.12406.508211126260307
  11. 11. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170:191-203. doi: 10.1016/s0021-9150(03)00097-2.14612198
  12. 12. Xie Y, Zhou T, Shen W, Lu G, Yin T, Gong L. Soluble cell adhesion molecules in patients with acute coronary syndrome. Chinese Medical Journal. 2000;113:286-288.
  13. 13. Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clinical Biochemistry. 2008;41:126-133. doi: 10.1016/j.clinbiochem.2007.09.001.18061588
  14. 14. Lino D, Freitas IA, Meneses GC, et al. Interleukin-6 and adhesion molecules VCAM-1 and ICAM-1 as biomarkers of post-acute myocardial infarction heart failure. Brazilian Journal of Medical and Biological Research [Revista Brasileira de Pesquisas Medicas e Biologicas]. 2019:52:e8658. doi: 10.1590/1414-431X20198658.688640031778438
  15. 15. Hayek A, Paccalet A, Mechtouff L, et al. Kinetics and prognostic value of soluble VCAM-1 in ST-segment elevation myocardial infarction patients. Immunity, Inflammation and Disease. 2021;9:493-501. doi: 10.1002/iid3.409.812755033559404
  16. 16. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2292-2301. doi: 10.1161/ATVBAHA.107.149179.17673705
  17. 17. Mulvihill NT, Foley JB, Crean P, Walsh M. Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur Heart J. 2002;23:1569-1574. doi: 10.1053/euhj.2002.3188.12323155
  18. 18. Hahn C, Schwartz MA. The role of cellular adaptation to mechanical forces in atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:2101-2107. doi: 10.1161/ATVBAHA.108.165951.273767918787190
  19. 19. Soroka V, Kasper C, Poulsen FM. Structural biology of NCAM. Adv Exp Med Biol. 2010;663:3-22. doi: 10.1007/978-1-4419-1170-4_1.20017012
  20. 20. Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment. Front Immunol. 2019;10:1078. doi: 10.3389/fimmu.2019.01078.655841831231358
  21. 21. Ley K, Huo Y. VCAM-1 is critical in atherosclerosis. J Clin Invest. 2001;107:1209-1210. doi: 10.1172/JCI13005.20930411375406
  22. 22. Oguchi S, Dimayuga P, Zhu J, et al. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1729-1736. doi: 10.1161/01.atv.20.7.1729.10894810
  23. 23. Sluiter TJ, van Buul JD, Huveneers S, Quax PHA, de Vries MR. Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis. Biomedicines. 2021;9:328. doi: 10.3390/biomedicines9040328.806393133804952
  24. 24. Silva R, D’Amico G, Hodivala-Dilke KM, Reynolds LE. Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol. 2008;28:1703-1713. doi: 10.1161/ATVBAHA.108.172015.18658045
  25. 25. Lu X, Lu D, Scully MF, Kakkar VV. The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities. Curr Pharm Des. 2008;14:2140-2158. doi: 10.2174/138161208785740199.18781968
  26. 26. Scott DW, Patel RP. Endothelial heterogeneity and adhesion molecules N-glycosylation: implications in leukocyte trafficking in inflammation. Glycobiology. 2013;23:622-633. doi: 10.1093/glycob/cwt014.23445551
  27. 27. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88-92. doi: 10.1016/S0140-6736(97)09032-6.9439492
  28. 28. Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001;107:1255-1262. doi: 10.1172/JCI11871.20929811375415
  29. 29. Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336-1342. doi: 10.1161/hc3701.095949.11560847
  30. 30. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001;103:491-495. doi: 10.1161/01.cir.103.4.491.11157711
  31. 31. Patel RB, Colangelo LA, Reiner AP, et al. Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life. J Am Coll Cardiol. 2020;75:2156-2165. doi: 10.1016/j.jacc.2020.02.060.730161132194198
  32. 32. Bossowska A, Kiersnowska-Rogowska B, Bossowski A, Galar B, Sowiński P. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction]. Przegl Lek. 2003;60:445-50. Polish.
  33. 33. Santos JCD, Cruz MS, Bortolin RH, et al. Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions. Clinics (Sao Paulo). 2018;73:e203. doi: 10.6061/clinics/2018/e203.596007429846413
  34. 34. Opincariu D, Rodean I, Rat N, Hodas R, Benedek I, Benedek T. Systemic Vulnerability, as Expressed by I-CAM and MMP-9 at Presentation, Predicts One Year Outcomes in Patients with Acute Myocardial Infarction-Insights from the VIP Clinical Study. J Clin Med. 2021;10:3435. doi: 10.3390/jcm10153435.834780634362217
  35. 35. Patel RB, Colangelo LA, Bielinski SJ, et al. Circulating Vascular Cell Adhesion Molecule-1 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc. 2020;9:e019390. doi: 10.1161/JAHA.120.019390.776372733161805
DOI: https://doi.org/10.2478/jce-2022-0009 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 59 - 63
Submitted on: Jul 17, 2022
|
Accepted on: Aug 1, 2022
|
Published on: Jan 27, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Diana Opincariu, Theodora Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.